Lack of efficacy of dual intragastric balloon therapy on weight loss and patient dissatisfaction.
American journal of surgery
BACKGROUND: Dual intragastric balloon (DIGB) therapy is a non-surgical, restrictive method of weight loss. We evaluated weight loss and patient satisfaction after DIGB removal.
METHODS: Between 2016 and 2019, 35 patients had DIGB therapy. A retrospective review of weight loss at balloon removal and follow-up, adverse events during DIGB therapy, and patient satisfaction was performed.
RESULTS: At follow-up after balloon removal (22.3 ± 10.5 months), mean percent excess weight loss (%EWL) was significantly decreased compared to %EWL at removal (4.7 ± 42.7% vs 32.4 ± 38.8%, p = .001). Weight regain occurred in 22/31 (71%) patients. Adverse events during DIGB therapy included: nausea, abdominal pain, reflux, pancreatitis, and gastric outlet obstruction. Twenty-five (71.4%) patients completed a satisfaction questionnaire. Only 3/25 (12%) patients were satisfied, and 92% would not choose DIGB for weight loss.
CONCLUSION: Weight loss achieved from DIGB on average was not maintained after balloon removal. Most patients were not satisfied and would not choose DIGB again.
Lew D, Thampy C, Hawasli A. Lack of efficacy of dual intragastric balloon therapy on weight loss and patient dissatisfaction. Am J Surg. 2021 Mar;221(3):581-584. doi: 10.1016/j.amjsurg.2020.11.010. Epub 2020 Nov 9. PMID: 33190789.